Brazil approves Pfizer Covid-19 vaccine for widespread use

Brazil has approved the Pfizer-BioNTech Covid-19 vaccine for use, although the jabs are not available in the country yet. – EPA pic, February 23, 2021.

BRAZIL’S health regulatory agency said today it has approved the Pfizer-BioNTech Covid-19 vaccine for widespread use, as the country races to secure enough doses to contain one of the world’s worst outbreaks.

“It gives me great pleasure to announce that after a 17-day review, (regulators) have granted the first approval in the Americas for widespread use of a vaccine against Covid-19,” said Antonio Barra Torres, the director of federal health regulator Anvisa, underlining that the approval was definitive and not only for emergency use.

Effective July 2018, access to full reports will only be available with a subscription. Sign-up now and enjoy one (1) week free access!

Subscribe Now!

Sign up or sign in here to comment.